Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (3108)
Seres Therapeutics, Inc. (MCRB)
Brady Kelly — EVP, Chief Operating Officer
Shares
64
Price
$4.55
Total Value
$291.20
Shares Held After
8,679
% of Holdings
0.7%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Wong Shelly — SVP, FINANCE AND CAO
Shares
573
Price
$1.93
Total Value
$1.11K
Shares Held After
87,828
% of Holdings
0.6%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Lettmann Jason — Director
Shares
2,230
Price
$1.93
Total Value
$4.30K
Shares Held After
294,379
% of Holdings
0.8%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — President and Chief Scientific Officer
Shares
81
Price
$4.55
Total Value
$368.55
Shares Held After
7,995
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
263
Price
$4.55
Total Value
$1.20K
Shares Held After
12,499
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,683
Price
$508.17
Total Value
$855.25K
Shares Held After
324,443
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,298
Price
$507.43
Total Value
$1.67M
Shares Held After
326,126
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,521
Price
$506.35
Total Value
$1.28M
Shares Held After
329,424
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,238
Price
$505.36
Total Value
$625.64K
Shares Held After
331,945
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$504.21
Total Value
$60.50K
Shares Held After
333,183
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
427
Price
$502.18
Total Value
$214.43K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
213
Price
$501.06
Total Value
$106.73K
Shares Held After
333,730
% of Holdings
0.1%
Verrica Pharmaceuticals Inc. (VRCA)
Zawitz David — Chief Operating Officer
Shares
6,000
Price
$4.98
Total Value
$29.88K
Shares Held After
27,000
% of Holdings
22.2%
Verrica Pharmaceuticals Inc. (VRCA)
Rosenberg Noah L. — CMO
Shares
4,200
Price
$4.91
Total Value
$20.62K
Shares Held After
6,557
% of Holdings
64.1%
Verrica Pharmaceuticals Inc. (VRCA)
Rieger Jayson — Director
Shares
5,000
Price
$4.91
Total Value
$24.55K
Shares Held After
207,593
% of Holdings
2.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
2,472
Price
$4.04
Total Value
$10.00K
Shares Held After
583,531
% of Holdings
0.4%
Relay Therapeutics, Inc. (RLAY)
Patel Sanjiv — Director
Shares
48,199
Price
$20.33
Total Value
$979.89K
Shares Held After
567,699
% of Holdings
7.8%
CORCEPT THERAPEUTICS INC (CORT)
Robb Gary Charles — Chief Business Officer
Shares
10,000
Price
$116.26
Total Value
$1.16M
Shares Held After
39,716
% of Holdings
20.1%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,400
Price
$0.93
Total Value
$5.02K
Shares Held After
381,115
% of Holdings
1.4%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
7,406
Price
$0.71
Total Value
$5.26K
Shares Held After
417,782
% of Holdings
1.7%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
5,020
Price
$0.71
Total Value
$3.56K
Shares Held After
425,188
% of Holdings
1.2%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
3,969
Price
$0.71
Total Value
$2.82K
Shares Held After
430,208
% of Holdings
0.9%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
5,837
Price
$0.71
Total Value
$4.14K
Shares Held After
434,177
% of Holdings
1.3%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
2,279
Price
$0.71
Total Value
$1.62K
Shares Held After
214,073
% of Holdings
1.1%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,871
Price
$0.71
Total Value
$1.33K
Shares Held After
216,352
% of Holdings
0.9%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,637
Price
$0.71
Total Value
$1.16K
Shares Held After
218,223
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,637
Price
$0.71
Total Value
$1.16K
Shares Held After
219,860
% of Holdings
0.7%
Alkermes plc. (ALKS)
Nichols Christian Todd — SVP, Chief Commercial Officer
Shares
664
Price
$49.65
Total Value
$32.97K
Shares Held After
102,193
% of Holdings
0.6%
Alkermes plc. (ALKS)
Nichols Christian Todd — SVP, Chief Commercial Officer
Shares
6,912
Price
$49.19
Total Value
$339.97K
Shares Held After
102,857
% of Holdings
6.3%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
3,000
Price
$4.37
Total Value
$13.12K
Shares Held After
3,087,000
% of Holdings
0.1%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
1,635
Price
$12.20
Total Value
$19.95K
Shares Held After
8,617
% of Holdings
15.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,480
Price
$112.56
Total Value
$279.15K
Shares Held After
32,718
% of Holdings
7.0%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
3,320
Price
$112.01
Total Value
$371.89K
Shares Held After
35,198
% of Holdings
8.6%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
300
Price
$110.52
Total Value
$33.16K
Shares Held After
38,518
% of Holdings
0.8%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
900
Price
$109.65
Total Value
$98.69K
Shares Held After
38,818
% of Holdings
2.3%
Kura Oncology, Inc. (KURA)
WILSON TROY EDWARD — Director
Shares
100,000
Price
$11.12
Total Value
$1.11M
Shares Held After
379,194
% of Holdings
26.4%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,449
Price
$1.63
Total Value
$3.99K
Shares Held After
2,896
% of Holdings
45.8%
Zentalis Pharmaceuticals, Inc. (ZNTL)
WALTERS GROUP — 10% Owner
Shares
4,335,000
Price
$3.50
Total Value
$15.17M
Shares Held After
17,844,973
% of Holdings
24.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
11,608
Price
$2.09
Total Value
$24.21K
Shares Held After
2,760,000
% of Holdings
0.4%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
900
Price
$246.91
Total Value
$222.22K
Shares Held After
2,900
% of Holdings
31.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
1,100
Price
$245.85
Total Value
$270.44K
Shares Held After
2,000
% of Holdings
55.0%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
243,177
Price
$36.23
Total Value
$8.81M
Shares Held After
18,630,739
% of Holdings
1.3%
MapLight Therapeutics, Inc. (MPLT)
Catalyst4, Inc. — 10% Owner
Shares
4,400,000
Price
$11.38
Total Value
$50.07M
Shares Held After
25,306,689
% of Holdings
17.4%
Adagene Inc. (ADAG)
DO CUONG V — Director
Shares
2,000
Price
$3.75
Total Value
$7.50K
Shares Held After
2,000
% of Holdings
100.0%
Verrica Pharmaceuticals Inc. (VRCA)
Rieger Jayson — Director
Shares
20,000
Price
$5.06
Total Value
$101.20K
Shares Held After
202,593
% of Holdings
9.9%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$19.74
Total Value
$349.73K
Shares Held After
140,568
% of Holdings
11.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
33,787
Price
$3.85
Total Value
$130.00K
Shares Held After
581,059
% of Holdings
5.8%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
2,279
Price
$112.64
Total Value
$256.71K
Shares Held After
1,074,543
% of Holdings
0.2%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
4,668
Price
$111.44
Total Value
$520.21K
Shares Held After
1,076,822
% of Holdings
0.4%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
3,053
Price
$110.49
Total Value
$337.34K
Shares Held After
1,081,490
% of Holdings
0.3%
Showing 101–150 of 3108 transactions (page 3 of 63)